GDNF in ideopathicParkinsons Disease

NCT03652363 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Parkinson Disease

Interventions

DRUG: glial cell line-derived neurotrophic factor

Sponsor

North Bristol NHS Trust